Vaccinating children: The pros and cons - 20/11/22
Highlights |
• | Vaccinating children against Covid 19 was motivated by potential benefit for the population and possible individual benefit, even if less frequent than for adults. |
• | Immunogenicity of vaccines in children was similar or superior to adults. |
• | No significant tolerance issue raised after evaluation and use in routine practice. |
Abstract |
Vaccinating children against Covid raised a debate, due to generally mild clinical presentation.
The decision to vaccinate teenagers was motivated by the global public health need: to decrease transmission to other age groups. Among adolescents, the efficacy (better immunity than in young adults) and safety of vaccines was clearly demonstrated. Among 5-to-12-year-olds, due to lower contamination the collective benefit is less clear, and when the m-RNA vaccines were available for this age group, the Omicron variant was predominant and their effect on non-severe infections and transmission had yet to be determined.
Individual benefit is based both on somatic criteria and on the child's schooling and mental health.
Children under 5 years of age received a 3 µg dose of vaccine, which is one tenth of the adult dose, resulting in immunogenicity similar to that of 16-to-25-year-olds.
Le texte complet de cet article est disponible en PDF.Keywords : Covid 19, Vaccination, Children, RNA vaccine
Plan
Vol 52 - N° 8S
P. S9-S11 - novembre 2022 Retour au numéro
Article précédent
- Heterologous prime boost COVID 19 vaccination
- O. Launay, P. Thill
- What progress has been made in treatment of immunocompromised COVID-19 patients?
- F. Ader, J. Bauer
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?